High Altitude: Clinical Trials

37 trials for High Altitude, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 not yet recruiting, 12 completed, 6 unknown, 2 enrolling by invitation. 23 Not applicable, 3 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable23Not yet recruiting 14, Completed 6, Unknown 2, Enrolling by invitation 1
Phase 43Completed 3
Phase 11Completed 1

Follow High Altitude: new trials by email Literature Review of High Altitude trials Research Report on High Altitude

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessment of Lung Function (Lufu) at Sea Level LA vs. High Altitude HA in Patients With Pulmonary Arterial Hypertension PAH
Re-ascent from sea level to 2850m - Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease
Not applicableNot yet recruitingSilvia Ulrich Somaini202026-09-252026-09-04
Sleep-Assessment in Patients Between High Altitude HA vs. Sea Level LA in Healthy Individuals H
Descent from 2850m to sea level and re-ascent back to 2850m - Healthy, Healthy Adult
Not applicableNot yet recruitingSilvia Ulrich Somaini142026-09-252026-09-03
Assessment of Total Pulmonary Resistance sPAP/CO Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAH
Descent from 2850m to sea level - Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease
Not applicableNot yet recruitingSilvia Ulrich Somaini202026-09-252026-09-04
Assessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in Healthy Individuals H
Descent and re-ascent (2850m, sea level) - Healthy, Healthy Adult
Not applicableNot yet recruitingSilvia Ulrich Somaini142026-09-252026-09-03
Assessment of Six-minute Walking Distance Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary Arterial Hypertension PAH
Re-Ascent sea level to 2850m - Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease
Not applicableNot yet recruitingSilvia Ulrich Somaini202026-09-252026-09-01
Assessment of Six-minute Walking Distance Between Sea Level LA vs. High Altitude HA After Re-ascent in Healthy Individuals
Re-Ascent sea level to 2850m - High Altitude, Healthy
Not applicableNot yet recruitingSilvia Ulrich Somaini142026-09-252026-09-01
Assessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in Patients With Pulmonary Arterial Hypertension PAH
Descent and re-ascent (2850m, sea level) - High Altitude Effects, High Altitude
Not applicableNot yet recruitingSilvia Ulrich Somaini202026-09-252026-09-03
Sleep-Assessment in Patients Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAH
Descent to sea level - Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease
Not applicableNot yet recruitingSilvia Ulrich Somaini202026-09-252026-09-03
Assessment of Six-minute Walking Distance 6MWD Between High Altitude HA vs. Sea Level LA in Healthy Individuals H
Descent from 2850m to sea level - High Altitude, Six-minute Walk Test
Not applicableNot yet recruitingSilvia Ulrich Somaini142026-09-252026-09-03
Assessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Healthy Individuals
Re-Ascent from sea level to 2850m - High Altitude, Healthy
Not applicableNot yet recruitingSilvia Ulrich Somaini142026-09-252026-09-04
Assessment of Six-minute Walking Distance 6MWD Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAH
Descent from 2850m to sea level - Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease
Not applicableNot yet recruitingSilvia Ulrich Somaini202026-09-252026-09-04
Assessment of Lung Function (Lufu) at Sea Level LA vs. High Altitude HA in Healthy Individuals
Re-ascent from sea level to 2850m - Healthy, Healthy Adult
Not applicableNot yet recruitingSilvia Ulrich Somaini142026-09-252026-09-04
Assessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary Arterial Hypertension PAH
Re-Ascent from sea level to 2850m - Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease
Not applicableNot yet recruitingSilvia Ulrich Somaini202026-09-252026-09-04
Assessment of Total Pulmonary Resistance sPAP/CO Between High Altitude HA vs. Sea Level LA in Healthy Individuals H
Descent from 2850m to sea level - High Altitude, Healthy Adult
Not applicableNot yet recruitingSilvia Ulrich Somaini142026-09-252026-09-04
The Study of Personalized Health Check-up Programs and Standards for High-altitude Migrant Populations
High Altitude
Not yet recruitingCapital Medical University3002025-06-302025-06-12
Postoperative Complications of Orthopedic Surgery in Patients From High-altitude Regions
Orthopedic Surgery, Postoperative Complications
Not yet recruitingWest China Hospital4002024-11-152024-10-15
The Effect of Acute High Altitude Exposure on Rescuer Performance and Patient Care
Acute high altitude exposure, Acute high altitude exposure, with supplementary oxygen, Subacute high altitude exposure, after having spent a night at high altitude - High Altitude, Hypobaric Hypoxia
Not applicableCompletedInsel Gruppe AG, University Hospital Bern202024-08-022026-04-29
HighCycle: Effect of Acetazolamide on Pulmonary Artery Pressure in Women Compared to Men
Acetazolamide, Placebo - High Altitude
Phase 4CompletedUniversity of Zurich3032024-07-152026-06-05
CO2 Supplement for Treatment of Acute Mountain Sickness
Breathing with CO2 during daytime and night at high altitude, Sleep and doing exercise test under inhalation of air - Acute Mountain Sickness, High Altitude
Not applicableCompletedState Key Laboratory of Respiratory Disease462024-06-072024-12-18
Protocol for Evaluating Physiological and Psychological Adaptation Mechanisms in Tibetan Plateau Environments
measurement - High Altitude
Enrolling by invitationPeking Union Medical College Hospital172024-05-172024-08-16

Showing 20 of 37. Sign in to see all of them.

Narrower conditions

Altitude Sickness (37)  ·  Hypoxia (13)  ·  Pulmonary Arterial Hypertension (7)  ·  Hypertension, Pulmonary (5)  ·  Mucopolysaccharidosis IV (2)  ·  Respiratory Aspiration (2)  ·  Sleep Apnea Syndromes (2)  ·  Arrhythmias, Cardiac (1)  ·  COVID-19 (1)  ·  Cardiotoxicity (1)  ·  Hypertension (1)  ·  Postoperative Complications (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Risk Reduction Behavior (1)  ·  Sleep Apnea, Central (1)

Broader conditions

Respiration Disorders (37)  ·  Respiratory Tract Diseases (37)  ·  Pathological Conditions, Signs and Symptoms (19)  ·  Signs and Symptoms (13)  ·  Signs and Symptoms, Respiratory (13)  ·  Lung Diseases (9)  ·  Cardiovascular Diseases (8)  ·  Pathologic Processes (6)  ·  Vascular Diseases (6)  ·  Hypertension (5)  ·  Apnea (3)  ·  Dyssomnias (3)  ·  Nervous System Diseases (3)  ·  Sleep Disorders, Intrinsic (3)  ·  Sleep Wake Disorders (3)

Interventions

Acetazolamide (1)  ·  CVS 1123 (1)  ·  Ibuprofen (1)  ·  Maltose (1)  ·  Nifedipine (1)  ·  Oxygen Saturation (1)  ·  Pioglitazone (1)  ·  Sea Level Rise (1)  ·  Sugars (1)  ·  Telmisartan (1)  ·  Ventilation (1)  ·  Weights and Measures (1)

Sponsors

Silvia Ulrich Somaini (14)  ·  United States Army Research Institute of Environmental Medicine (3)  ·  Peking University People's Hospital (2)  ·  State Key Laboratory of Respiratory Disease (2)  ·  University of Zurich (2)  ·  Affiliated Hospital of Qinghai University (1)  ·  Ataturk University (1)  ·  Beijing Chao Yang Hospital (1)  ·  Capital Medical University (1)  ·  Centre d'Expertise sur l'Altitude EXALT (1)  ·  Giresun University (1)  ·  IU University of Applied Sciences (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Istituto Auxologico Italiano (1)  ·  Nanjing Medical University (1)

Countries

Switzerland (15)  ·  China (9)  ·  United States (4)  ·  Kyrgyzstan (2)  ·  Peru (2)  ·  Turkey (Türkiye) (2)  ·  Germany (1)

Top investigators

Rodrigo Hoyos (14)  ·  Silvia Ulrich (14)  ·  Yi Feng (2)  ·  Yuanming Luo, PhD (2)  ·  Chunling Jiang, PhD (1)  ·  Dilek Yeniay (1)  ·  Gianfranco Parati, MD, PhD (1)  ·  John Feiner, MD (1)  ·  Juergen Knapp, PD, MD (1)  ·  Lee M Margolis, PhD (1)  ·  Liu Xiaoqin, Bachelor (1)  ·  Martina Heer, PhD (1)  ·  Philip Bickler, PhD/MD (1)  ·  Rui Wang, Dr. (1)  ·  Silvia Ulrich, Prof (1)

Results publications

PMID 15220175, PMID 17339571, PMID 19921365, PMID 21654697, PMID 239384, PMID 25895588, PMID 26357836, PMID 29886423, PMID 32333993, PMID 32679369, PMID 32803989, PMID 32815745, PMID 32971150, PMID 33054403, PMID 34197184, PMID 35280910, PMID 35459680, PMID 36376852, PMID 42429551, PMID 5556959, PMID 9667290